Aquisição Medicamento Miricizumab inj. 20mg/ml 300mg/15ml iv_miricizumab caneta 100mg/1ml sc

ID 11773935 · Portal BASE
Price
Base Price
€11,525 .00
Effective Price
€11,525 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Porto, Porto
Bidder Count
—
Winner
LILLY-PORTUGAL PRODUTOS FARMACÊUTICOS LDA
NIF 500165602
Company
Dates
Publication
08 Oct 2025
Celebration
21 Jul 2025
Contracting Entity
Unidade Local de Saúde de Santo António, EPE
NIF 517392259
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 90 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
745
Supplier
263
Number of Awards
5
Rule
A1 repeat direct award: 5 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
08 Oct 2025
Signing Date
21 Jul 2025
Days Late
79
Rule
A2/A3 late publication: 79 days after signing (threshold: 10)
Detected 2026-03-06